Amalgamated Bank’s Tango Therapeutics TNGX Stock Holding History

Amalgamated Bank’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,341	Closed	-$30K	–	2717
2025 Q4	$30K	Buy	3,341 +1,723	+106%	+$14.8K	﹤0.01%	1971
2025 Q3	$14K	Hold	1,618	–	–	﹤0.01%	2317
2025 Q2	$8K	Hold	1,618	–	–	﹤0.01%	2556
2025 Q1	$2K	Hold	1,618	–	–	﹤0.01%	2877
2024 Q4	$5K	Hold	1,618	–	–	﹤0.01%	2759
2024 Q3	$12K	Hold	1,618	–	–	﹤0.01%	2377
2024 Q2	$14K	Hold	1,618	–	–	﹤0.01%	2283
2024 Q1	$13K	Sell	1,618 -2,389	-60%	-$25.6K	﹤0.01%	2335
2023 Q4	$40K	Sell	4,007 -482	-11%	-$4.18K	﹤0.01%	2346
2023 Q3	$51K	Hold	4,489	–	–	﹤0.01%	2246
2023 Q2	$15K	Sell	4,489 -336	-7%	-$1.21K	﹤0.01%	2877
2023 Q1	$19K	Sell	4,825 -1,081	-18%	-$6.27K	﹤0.01%	2674
2022 Q4	$43K	Hold	5,906	–	–	﹤0.01%	2492
2022 Q3	$21K	Hold	5,906	–	–	﹤0.01%	2808
2022 Q2	$27K	Buy	+5,906	New	+$35.8K	﹤0.01%	2771

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Amalgamated Bank's TNGX Position: Q1 2026 in Review

Amalgamated Bank sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 3,341 shares — an estimated $30K sold.

Amalgamated Bank first reported a position in TNGX in Q2 2022 and held it in 15 quarters. The position peaked at $51K in Q3 2023. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

Amalgamated Bank reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 3,341 Tango Therapeutics shares in Q1 2026, an estimated $30K.
Amalgamated Bank first reported a position in Tango Therapeutics in Q2 2022 and held it in 15 quarters.
Amalgamated Bank's Tango Therapeutics position peaked at $51K in Q3 2023.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.